300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Film
Oil and Gas
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Recruiting
Sustainability
Hardware
Biotech
Transportation
Web3
Enterprise
Community
Media (Entertainment)
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
Oman
LATAM
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
Kenya
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
Ireland
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science VC Funds & Investors in France (October 2026)

The most active venture capital funds investing in France Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in France Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Bpifrance
VC Fund
28 France, United States, Switzerland Seed, Venture - Series Unknown, Series A Software, Health Care, Biotechnology $752k–$34M
Kurma Partners
VC Fund
9 France, Switzerland, Spain Series A, Seed, Series B Health Care, Biotechnology, Pharmaceutical $2.8M–$98M
Idinvest Partners
VC Fund
7 France, United States, Germany Series A, Series B, Venture - Series Unknown Software, Health Care, Biotechnology $3.4M–$66M
Seventure Partners
VC Fund
7 France, United States, Germany Series A, Series B, Seed Biotechnology, Software, Health Care $1.1M–$63M
Omnes Capital
VC Fund
6 France, Germany, United States Series A, Series B, Venture - Series Unknown Biotechnology, Software, Health Care $3.8M–$53M
Sofinnova Partners
VC Fund
5 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
Eurazeo
VC Fund
5 France, United States, United Kingdom Venture - Series Unknown, Seed, Series B Software, Information Technology, Health Care $3.2M–$156M
Elaia
VC Fund
5 France, United States, Spain Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.1M–$50M
Angels Santé
VC Fund
4 France, India, United States Seed, Venture - Series Unknown, Angel Health Care, Biotechnology, Medical Device $664k–$8.2M
Paca Investissement
VC Fund
4 France Seed, Venture - Series Unknown Software, Internet, Manufacturing $325k–$5.2M
AdBio partners
VC Fund
4 France, Spain, Belgium Seed, Series A, Venture - Series Unknown Biotechnology, Health Care, Pharmaceutical $2.2M–$37M
Blue Horizon Corporation
VC Fund
3 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Food and Beverage, Food Processing, Biotechnology $450k–$40M
Galia Gestion
VC Fund
3 France, United States Venture - Series Unknown, Series A Software, Manufacturing, Biotechnology $849k–$11M
Beyond Impact
VC Fund
3 United States, France, United Kingdom Seed, Series A, Venture - Series Unknown Food and Beverage, Food Processing, Biotechnology $670k–$14M
Entrepreneurs First
VC Fund
3 United Kingdom, Singapore, United States Seed, Pre-Seed, Series A Artificial Intelligence, Software, Machine Learning $54k–$41M
Advent Life Sciences
VC Fund
3 United States, United Kingdom, France Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $5.5M–$104M
Boehringer Ingelheim Venture Fund
VC Fund
3 United States, Germany, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.8M–$50M
XAnge
VC Fund
3 France, Germany, Belgium Seed, Series A, Series B Software, SaaS, Health Care $1.1M–$75M
Social Starts
VC Fund
3 United States, Canada, Germany Seed, Series A, Venture - Series Unknown Software, Health Care, Artificial Intelligence $50k–$14M
Karista
VC Fund
3 France, United States, Finland Seed, Series A, Series B Software, Biotechnology, Health Care $768k–$33M
Lundbeckfonden Ventures
VC Fund
2 United States, Denmark, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $10M–$95M
Mtec Holding Gmbh
VC Fund
2 France Seed, Series A Computer, Health Care, Life Science
Polytechnique Ventures
VC Fund
2 France, United Kingdom, Germany Seed, Series A, Pre-Seed Biotechnology, Robotics, Information Technology $1.3M–$17M
Beurer
VC Fund
2 Germany, France, Estonia Seed, Series A, Pre-Seed Health Care, Medical, Software $1.2M–$10M
InnoBio Fund
VC Fund
2 France, United States Series A, Series B, Series C Biotechnology, Therapeutics, Pharmaceutical $14M–$26M
Wendel Growth
VC Fund
2 France, Luxembourg Series A, Venture - Series Unknown Analytics, Open Source, Biotechnology $16M–$38M
WiSEED
VC Fund
2 France, Norway Seed, Venture - Series Unknown, Series A Software, Biotechnology, Manufacturing $392k–$7.8M
Partech
VC Fund
2 France, United States, Germany Seed, Series A, Series B Software, Artificial Intelligence, E-Commerce $1M–$56M
IRDI SORIDEC Gestion
VC Fund
2 France, Brazil, Singapore Seed, Series A, Venture - Series Unknown Software, Biotechnology, Medical $1.3M–$13M
JDRF T1D Fund
VC Fund
2 United States, Canada, France Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $7M–$130M
Alexandria Venture Investments
VC Fund
2 United States, Canada, France Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$150M
European Commission
VC Fund
2 France, Spain, Germany Grant, Seed, Pre-Seed Software, Biotechnology, Artificial Intelligence $55k–$51M
Kinled Holding
VC Fund
2 United Kingdom, United States, Switzerland Seed, Series A Biotechnology, Health Care, Software $594k–$40M
Horizons Ventures
VC Fund
2 United States, United Kingdom, Canada Series A, Series B, Seed Artificial Intelligence, Software, Biotechnology $1M–$110M
Point Nine
VC Fund
2 Germany, United States, France Seed, Series A, Series B Software, SaaS, Artificial Intelligence $900k–$62M
Invus
VC Fund
2 United States, France, United Kingdom Series B, Series C, Series A Biotechnology, Health Care, Therapeutics $14M–$230M
Air Street Capital
VC Fund
2 United States, United Kingdom, France Seed, Series A, Pre-Seed Artificial Intelligence, Software, Biotechnology $1.1M–$48M
AQUITI Gestion
VC Fund
2 France, United States Venture - Series Unknown, Seed, Series A Software, Biotechnology, Manufacturing $531k–$18M
Thia Ventures
VC Fund
2 United States, France, Denmark Series A, Seed, Pre-Seed Biotechnology, Health Care, Manufacturing $3.4M–$48M
Sofimac Investment Managers
VC Fund
2 France, Italy, Austria Venture - Series Unknown, Seed Health Care, Biotechnology, Manufacturing $268k–$8.7M
Heartcore Capital
VC Fund
2 United States, Denmark, Germany Seed, Series A, Series B Software, Artificial Intelligence, E-Commerce $1.2M–$58M
Eutopia VC
VC Fund
2 France, Belgium, Denmark Seed, Series A, Venture - Series Unknown E-Commerce, Retail, Food and Beverage $1.3M–$48M
Siparex Groupe
VC Fund
2 France, United States, Italy Private Equity, Series A Manufacturing, Software, Information Technology $1.5M–$27M
Agrinvest
VC Fund
1 France, United States, Belgium Series B, Series A Software, Biotechnology, E-Commerce
ADI Nouvelle-Aquitaine
VC Fund
1 France Seed Life Science, Biotechnology, Waste Management
Inserm Transfert Initiative
VC Fund
1 France, Switzerland, United States Series A, Series B, Seed Biotechnology, Medical, Health Care
Crédit Mutuel Innovation
VC Fund
1 France, United States, Canada Series A, Series B Software, Health Care, Biotechnology
Societe Generale Asset Management
VC Fund
1 France, United States, Germany Series B, Series A Biotechnology, Software, Health Care
Gimv
VC Fund
1 Belgium, United States, France Series B, Private Equity Biotechnology, Health Care, Medical
Florac
VC Fund
1 France Series A, Private Equity Sales, E-Commerce, Health Care
Access all 322 VC funds in France Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 28 investments in France Life Science startups

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 1710
  • Round size: Seed $752k–$6.1M; Series A $2.6M–$34M; Venture - Series Unknown $1.1M–$31M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely actively investing — fresh fund, raised $27M in 2025

Portfolio highlights

  • Cube — Cube is a French accelerator for tech startups, particularly in Web3, blockchain, and innovation, rebranded from Cube3. It provides a 9-month program combining strategic mentoring, customized funding, media production, and investor networking to scale promising ventures.
  • Ostrea — OSTREA is a pioneering company in the creation of high-performance materials based on bio-minerals: seashells.
  • NeoXperiences — NeoXperiences develops technological solutions that bring audiences together around fun and interactive experiences.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 9 investments in France Life Science startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Stage:Series A, Seed, Series B
  • Geography: France, Switzerland, Spain

Investor stats

  • Total investments: 145
  • Round size: Seed $2.8M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — raised $236M in 2024

Portfolio highlights

  • Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
  • AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
  • Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Show all investments...

Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 7 investments in France Life Science startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 350
  • Round size: Series A $3.4M–$22M; Series B $7.8M–$66M; Venture - Series Unknown $4.1M–$37M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $97M in 2021

Portfolio highlights

  • Actility — Actility provides IoT connectivity and solutions to power smart cities and industries.
  • Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
  • StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 7 investments in France Life Science startups

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 274
  • Round size: Seed $1.1M–$4.7M; Series A $3.2M–$28M; Series B $3.4M–$63M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Ekstere — Ekstere facilitates selling and purchasing verified-quality used bicycles at a reasonable price.
  • Flexvelop — Flexvelop is a fintech transforming the way businesses finance essential business equipment. "Flexing" is an innovative combination of leasing, renting and bank-financing terms offering a kind of Hardware-as-a-Service solution. Embedded as a payment solution, partnered manufacturers, vendors and brands are actively offering"Flexing" to their b2b customers for financing new business equipment right at the point of sale and in online shops. Flexvelop is operating in the verticals of office-it, hospitality equipment, medical devices or fitness equipment throughout Germany. Well-known manufacturers like Lenovo, WMF, or LaMarzocco are using Flexing openly or as a white-label solution. SMB customers flex equipment to grow flexibly without the usual investment risk – saving liquidity, tax and a clean balance sheet. Flexvelop is using its patented in-house financing technology, promoting a more sustainable circular economy in the same time. Flexing becomes the new standard for business equipment procurement for SMBs throughout Germany, Europe and beyond.
  • Presto Engineering — We enable companies imagine and implement microelectronics solutions in high-value markets such as Industrial, Automotive, Communication and Medical.
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France · 6 investments in France Life Science startups

Omnes Capital takes a unique approach to renewable energy, transforming developers into independent power producers to provide green energy to millions.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: France, Germany, United States

Investor stats

  • Total investments: 186
  • Round size: Series A $4.3M–$41M; Series B $4.4M–$53M; Venture - Series Unknown $3.8M–$46M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely actively investing — fresh fund, raised $132M in 2025

Portfolio highlights

  • Adictiz — Adictiz, a French company founded in 2009 by Charles Christory, develops and publishes social games for the web and mobile phones.With successful brands including “Space Dog” and “What a Stupid Pigeon”, which attract close to 2.5 million players every month, Adictiz has established itself as an expert player in social and mobile gaming.Basedat the EuraTechnologies economic excellence hub in Lille, which is dedicated to serving information and communication technology companies, Adictiz set up Adictiz Studio in late 2011, which specialises in the creation of customised social games for brands. Adictiz Studio was recently selected by Facebook as a PMD (Preferred Marketing Developer).
  • Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
  • EnduroSat — Enabling profitable LEO satellite constellations with standardized satellites and fixed-cost space service. 100+ satellites deployed to orbit
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 5 investments in France Life Science startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 353
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
  • EnginZyme — Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at industrial scale.
Show all investments...

Eurazeo
VC Fund · Paris, Ile-de-France, France · 5 investments in France Life Science startups

Eurazeo is a private equity and venture capital firm that invests in SMEs and manages a diversified portfolio of assets.With its expertise in private equity, real estate, and private debt, the group supports companies of all sizes in their development commitment through the commitment of its 235 professionals. It provides companies with thenecessary investments needed to realize their growth potential.The firm was founded in 1969 and is based in Paris, Ile-de-France, France.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Venture - Series Unknown, Seed, Series B
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 384
  • Round size: Seed $3.2M–$16M; Series B $17M–$125M; Venture - Series Unknown $7.8M–$156M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely actively investing — fresh fund, raised $2.6B in 2026

Portfolio highlights

  • Excelya — Excelya is an R&D company that specializes in consulting, clinical trials, therapeutic research, data management, and medical writing.
  • Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
  • Celcius Logistics Solutions — India's Largest 'ONLINE " cold chain network.Book reefer vehicles, Cold Storages or get booking for your vehicle and cold storages across India instantly with the best price
Show all investments...

Elaia
VC Fund · Paris, Ile-de-France, France · 5 investments in France Life Science startups

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 241
  • Round size: Seed $1.1M–$7.6M; Series A $2.7M–$23M; Series B $4.2M–$50M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely actively investing — fresh fund, raised $154M in 2026

Portfolio highlights

  • Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
  • RelaiSanté — RelaiSanté provides a digital platform that connects hospitals and home care providers to coordinate patient return home.
  • Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
Show all investments...

Angels Santé
VC Fund · Puteaux, Ile-de-France, France · 4 investments in France Life Science startups

Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Venture - Series Unknown, Angel
  • Geography: France, India, United States

Investor stats

  • Total investments: 37
  • Round size: Seed $1.1M–$4.6M; Angel $687k–$1.3M; Venture - Series Unknown $664k–$8.2M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
  • StemInov — StemInov is developing a stem cell therapy for inflammatory diseases with a first focus on critical care: septic shock and ARDS
  • SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.
Show all investments...

Paca Investissement
VC Fund · Paris, Ile-de-France, France · 4 investments in France Life Science startups

Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.

Show more...

Investment focus

  • Industry: Software, Internet, Manufacturing
  • Stage:Seed, Venture - Series Unknown
  • Geography: France

Investor stats

  • Total investments: 73
  • Round size: Seed $325k–$1.7M; Venture - Series Unknown $1.1M–$5.2M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
  • SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
  • C4Diagnostics — Dana69 adalah tempat penyedia link login game online yang bisa di mainkan dengan menggunakan smartphone android dan iphone dan bisa melakukan top up slot dana 10k atau slot deposit dana 10k selalu online 24 jam.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
AdBio partners
VC Fund · Paris, Ile-de-France, France · 4 investments in France Life Science startups

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: France, Spain, Belgium

Investor stats

  • Total investments: 32
  • Round size: Seed $2.2M–$18M; Series A $18M–$37M; Venture - Series Unknown $2.2M–$16M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $116M in 2021

Portfolio highlights

  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
  • Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Show all investments...

Blue Horizon Corporation
VC Fund · Zürich, Zurich, Switzerland · 3 investments in France Life Science startups

Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 109
  • Round size: Seed $2M–$10M; Pre-Seed $450k–$6.3M; Series A $2M–$40M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $222M in 2021

Portfolio highlights

  • WOW EARN — Discover WOW EARN, the all-in-one Web3 app with crypto mining, multi-chain wallet, staking NFTs, and marketplace dApps. Join the global Web3 community today.
  • EV Biotech — DANU strain engineering creates Precision Biopolymers For High-Performance Applications through strain engineering and AI.
  • foodforecast — AI supported solution to reduce food waste.
Show all investments...

Galia Gestion
VC Fund · Bordeaux, Aquitaine, France · 3 investments in France Life Science startups

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Biotechnology
  • Stage:Venture - Series Unknown, Series A
  • Geography: France, United States

Investor stats

  • Total investments: 55
  • Round size: Series A $849k–$7.2M; Venture - Series Unknown $1.3M–$11M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $26M in 2013

Portfolio highlights

  • Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
  • Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
  • Mon Chasseur Immo — Mon Chasseur Immo is a Real Estate, based in Languedoc Roussillon.
Show all investments...

Beyond Impact
VC Fund · Montreux, Vaud, Switzerland · 3 investments in France Life Science startups

Beyond Impact Advisors is created to facilitate investment in products and services that are either inherently vegan in nature or are cruelty-free and remove mankind’s reliance on the raising of animals for slaughter.Beyond Impact’s core investment thesis centers on sustainability as a pillar of risk management and economic valuation. Due to theheavy environmental impact, the use of animals is inherently unsustainable and alternatives need to be found and funded. Coinciding with this we are seeing an accelerating societal shift in favour of vegan, cruelty-free and plant-based alternatives, based on the environmental imperative, health concerns and compassion for animals.As such, Beyond Impact targets significantly impactful companies which have positioned their products and services to meet this growing demand, favouring those with clear technological advantages and whose products outstrip the qualities of the animal-derived material they replace.

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Biotechnology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 41
  • Round size: Seed $670k–$7M; Series A $2.9M–$14M; Venture - Series Unknown $2.1M–$2.3M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Jay&Joy — Jay&Joy is the first plant-based creamery in France engaged in manufacturing alternatives to cheese made from almond milk and cashew nuts.
  • Paleo — Paleo creates animal-free and GMO-free ingredients for plant-based meat and fish alternatives. They enhance taste, aroma, color and nutritional value.
  • Perfat Technologies — Perfect fats for better foods.
Show all investments...

Entrepreneurs First
VC Fund · London, England, United Kingdom · 3 investments in France Life Science startups

We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Singapore, United States

Investor stats

  • Total investments: 485
  • Round size: Seed $54k–$6.7M; Pre-Seed $55k–$2.7M; Series A $5.1M–$41M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: Likely actively investing — fresh fund, raised $133M in 2026

Portfolio highlights

  • ByteAsk — Derisk your AI agents
  • Sourcepulse — Your early warning system for software delivery (YC S23)
  • Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
Show all investments...

Advent Life Sciences
VC Fund · London, England, United Kingdom · 3 investments in France Life Science startups

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 73
  • Round size: Series A $5.5M–$51M; Series B $21M–$97M; Venture - Series Unknown $7M–$104M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
  • Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 3 investments in France Life Science startups, 7 in the past 12 months

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 108
  • Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2018

Portfolio highlights

  • Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
Show all investments...

XAnge
VC Fund · Paris, Ile-de-France, France · 3 investments in France Life Science startups

XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: France, Germany, Belgium

Investor stats

  • Total investments: 240
  • Round size: Seed $1.1M–$8M; Series A $3M–$22M; Series B $6M–$75M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $261M in 2021

Portfolio highlights

  • ELDIM — Eldim proposes photometric and calorimetric products of instrumentation allowing to qualify the ergonomic parameters and the quality of the image of the flat screens. Its customers (manufacturers of components or sreen-Sharp, Sony, Samsung, -or integrators-IBM, Apple, Valeo, Honeywell, Nokia, Motorola-) are mainly foreigns.
  • Skello — Skello is the The AI HR solution for frontline teams. HR tools were designed for offices, yet 55% of the workforce works on their feet and deserves technology designed for the field. Our mission is to improve their daily lives. For managers and HR directors, Skello offers seamless management from hiring to the payslip: our AI automatestime-consuming tasks so they can anticipate and supervise while maintaining full control. For teams, Skello guarantees a transparent and collaborative experience from their very first day. In July 2026, we reached a major milestone with the announcement of €200 million in funding to accelerate our development. After 10 years spent listening to our customers, this new chapter solidifies our conviction: technology must assist and facilitate work, without ever replacing humans. Our ambition is to be the go-to AI HR management solution for all frontline teams in Europe.
  • Intent Technologies — Intent Technologies provides a dedicated service platform for real estate players that allows them to optimize the operation of a heritage and build and distribute their services. The platform integrates a growing connected ecosystem including real estate managers (social and private landlords, trustee, real estate, communities, etc.), serviceproviders (facility management, energy, elevators, personal services, insurance, etc.), publishers business software (BIM, ERP, CRM, CMMS, BI, etc.) and IoT solution providers.
Show all investments...

Social Starts
VC Fund · San Francisco, California, United States · 3 investments in France Life Science startups

Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, Canada, Germany

Investor stats

  • Total investments: 444
  • Round size: Seed $50k–$3.6M; Series A $3.1M–$14M; Venture - Series Unknown $626k–$6.1M
  • Lead/follow: 2% lead, 98% follow
  • Last fund: Likely still investing — raised $8.9M in 2022

Portfolio highlights

  • Mae Health — Mae is a maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes.
  • Ruby Bio — Ruby Bio is a biosynthesis platform that can manufacture complex molecules that are biodegradable and non-toxic. Ruby Bio uses naturally occurring yeast as a factory to convert low-cost sugar into high-value products.
  • Funnel — Our revolutionary CRM property management software saves both time and money for agents and owners while making leasing more efficient.
Show all investments...

Karista
VC Fund · Paris, Ile-de-France, France · 3 investments in France Life Science startups

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Finland

Investor stats

  • Total investments: 161
  • Round size: Seed $768k–$6.2M; Series A $1.4M–$23M; Series B $2.5M–$33M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — raised $44M in 2021

Portfolio highlights

  • Kynogon — Autodesk game middleware products, including Beast, Navigation, HumanIK and Scaleform, will no longer be available for purchase.
  • Voluntis — Voluntis design digital therapeutics to people across multiple areas to self-manage their treatment improving real-world outcomes.
  • DBV Technologies — DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Lundbeckfonden Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in France Life Science startups

Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 72
  • Round size: Series A $10M–$50M; Series B $20M–$95M; Series C $10M–$53M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
  • SNIPR Biome — We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
  • Women in Life Science Denmark — WiLD is a networking platform for women in senior positions in business and academia that is motivating and focused on science.
Show all investments...

Mtec Holding Gmbh
VC Fund · 2 investments in France Life Science startups

Holding Company

Show more...

Investment focus

  • Industry: Computer, Health Care, Life Science
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PKVitality — PKvitality is an advanced bio-wearable company. Fusing 20 years of expertise in consumer electronics with 20 years of biological research, PKvitality brings its patented SKinTaste technology to market. SKinTaste is a revolutionary biosensor array that uses micro-needles (<1mm long) to collect and analyze chemical compositions of the interstitialfluid found just below the surface of the skin. Using this technology, PKvitality is developing K'Watch, a continuous glucose monitor in the form of a smartwatch to change the lives of millions of diabetics.
Show all investments...

Polytechnique Ventures
VC Fund · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Polytechnique Ventures support entrepreneurs from the School's ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: France, United Kingdom, Germany

Investor stats

  • Total investments: 26
  • Round size: Seed $2M–$11M; Pre-Seed $1.3M–$2.7M; Series A $6.5M–$17M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $39M in 2023

Portfolio highlights

  • Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
  • Goodvest — Goodvest is an investment app (life insurance) that builds a better world, in line with your values and promoting performance.
  • Jimmy — Jimmy develops and operates thermal generators that supply industrial facilities with process heat produced through nuclear fission. The company designs compact generators that use high-temperature reactor technology to create heat without combustion and deliver it to industrial systems through heat transfer circuits. Its systems connect to factoryinfrastructure and provide heat for processes such as steam production, thermal oil heating, or hot air generation. Jimmy installs, operates, and manages these generators as integrated energy units adapted to the heat demand of each industrial site. The technology relies on micro-reactor architecture and modular deployment so multiple units can be combined to match required thermal output. Through this approach, Jimmy provides industrial heat that replaces fossil-fuel-based heat sources in manufacturing and processing operations.
Show all investments...

Beurer
VC Fund · Ulm, Baden-Wurttemberg, Germany · 2 investments in France Life Science startups

We offer a range of more than 500 products, and ever since 1919 we have been delivering what our claim promises: health and wellness. Our product ranges will ensure you feel great all-round! From medical products specialized in prevention and diagnosis, to weight and diagnosis products, as well as therapy devices an

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, France, Estonia

Investor stats

  • Total investments: 6
  • Round size: Seed $1.2M–$2.5M; Series A $6.8M–$10M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • PKVitality — PKvitality is an advanced bio-wearable company. Fusing 20 years of expertise in consumer electronics with 20 years of biological research, PKvitality brings its patented SKinTaste technology to market. SKinTaste is a revolutionary biosensor array that uses micro-needles (<1mm long) to collect and analyze chemical compositions of the interstitialfluid found just below the surface of the skin. Using this technology, PKvitality is developing K'Watch, a continuous glucose monitor in the form of a smartwatch to change the lives of millions of diabetics.
  • Healthy Networks — Healthy Networks flagship product, LungPass, is a smart stethoscope for lungs. It distinguishes serious and mild respiratory conditions by analysing lung sounds & symptoms. Easy to use, precise and affordable, LungPass is poised to become a go-to solution for people to own their respiratory health and for healthcare providers to expand theirservice coverage.
  • microsynetics GmbH — Developing hardware and software to help elderly people gaining more freedom and quality of life. Our first product is an emergency wristband which works together with an app, also connecting relatives via smartphone and phone integrated in the emergency wristband. The automated AI-based fall detection guarantees help even when the user - afteraccident - isn't capable anymore of activating the emergency call via integrated button.
Show all investments...

InnoBio Fund
VC Fund · Maisons-alfort, Ile-de-France, France · 2 investments in France Life Science startups

InnoBio is a French venture capital fund of €140 million, managed by CDC Enterprises (www.cdcentreprises.fr) and for 37 per cent subscribed by the FSI and leading international pharmaceutical companies in France. The fund makes direct equity and quasi-equity investments in companies that provide innovative technological products and services in thehealthcare market.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States

Investor stats

  • Total investments: 14
  • Round size: Series A $16M–$21M; Series B $14M–$21M; Series C $18M–$26M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Millendo Therapeutics — Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.
  • Diotheris — Diotheris develops bacterial therapies of the human skin and mucosal microbiome intended to protect against pathogenic bacteria. The company's products are based on live bacteria includes NASOFLORE which targets Staphylococcus aureus, enabling the prevention of infections due to major pathogen and protecting patients against biologicalthreats.
  • AlgoTherapeutix — AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.
Show all investments...

Wendel Growth
VC Fund · 2 investments in France Life Science startups

Wendel Growth is an investment arm of Wendel.

Show more...

Investment focus

  • Industry: Analytics, Open Source, Biotechnology
  • Stage:Series A, Venture - Series Unknown
  • Geography: France, Luxembourg

Investor stats

  • Total investments: 6
  • Round size: Series A $33M–$38M; Venture - Series Unknown $16M–$16M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • AQEMIA — Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success.
  • TaDaweb — Tadaweb is the first small data platform to scale Open Source intelligence for discovering and analysing information on the Internet.
Show all investments...

WiSEED
VC Fund · Toulouse, Midi-Pyrenees, France · 2 investments in France Life Science startups

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: France, Norway

Investor stats

  • Total investments: 34
  • Round size: Seed $392k–$3.3M; Series A $1.3M–$7.8M; Venture - Series Unknown $1M–$6.5M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
  • Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
  • BiPER Therapeutics — BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
Show all investments...

Partech
VC Fund · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 694
  • Round size: Seed $1M–$8.8M; Series A $4.5M–$28M; Series B $9M–$56M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely actively investing — fresh fund, raised $345M in 2026

Portfolio highlights

  • Modeinspect — acreom is the integrated markdown knowledge base with tasks. Your personal daily driver for your dev workflow.
  • TeamToolz — TeamToolz creates and implements user-friendly applications that simplify and streamline the creation, management and archiving of marketing communications. Addressing the urgency of time to market, our web-based tools better enable entire brand launches by coordinating the workflow of multiple outside agencies and internal groups, for moreintegrated worldwide brand management.
  • Revibe — Buy refurbished & used electronics (Smartphones, Laptops) in UAE at Revibe. Free delivery & 12 months warranty. Certified tech by our experts. Order Now!
Show all investments...

IRDI SORIDEC Gestion
VC Fund · Toulouse, Midi-Pyrenees, France · 2 investments in France Life Science startups

IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Medical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: France, Brazil, Singapore

Investor stats

  • Total investments: 54
  • Round size: Seed $1.7M–$5.8M; Series A $3.7M–$13M; Venture - Series Unknown $1.3M–$12M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Donecle — Automated aircraft inspections by drone for airlines and MRO. Donecle makes aircraft maintenance faster, safer and more reliable. Our unique technology combines 100% automated drone and image analysis algorithms to detect defects, lightning strikes, evaluate paint wear and check placards.
  • Nepting — NEPTING is a company specializing in payment solutions and services with the main objective of supporting business in its evolution. Listening to its customers, it brings a skill, a culture, an innovative offer for all existing, emerging and future payment methods.NEPTING equips all types of points of acceptance with its multi-channel andmulti-vendor electronic payment system and its secure solutions in compliance with the standards in force. It is distinguished by its ability to give its customers the many advantages of a single and homogeneous offer for all its sales channels: mPOS, Retail, TPE, Automate, e-commerce ...
  • ThIA Santé Mentale —
Show all investments...

JDRF T1D Fund
VC Fund · Boston, Massachusetts, United States · 2 investments in France Life Science startups

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 56
  • Round size: Series A $7M–$105M; Series B $18M–$130M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Zag Bio — Zag Bio is harnessing the immune system in a whole new way by targeting the thymus to change treatment possibilities for millions of patients with autoimmune diseases.
  • Tetragenetics — Our protein production platform provides recombinant transmembane proteins, including ion channels and GPCRs, for antibody drug discovery
  • vTv Therapeutics — vTv Therapeutics, a pharmaceutical company, focuses on the discovery and development of human therapeutics to fill unmet medical needs. Its mission is to utilize its innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines.vTv Therapeutics has a pipeline of small molecule clinicaland pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, metabolic disorders, inflammation, and cancer. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts. The quality and breadth of vTv's product candidate pipeline, platform technology, scientific team, and strategic collaborations have enabled it to become a fully integrated pharmaceutical company.The company's commitment to drug discovery is reflected in its medical solutions and the many exciting potential new treatment options in its pipeline. The company's major R&D activities have focused on central nervous system disorders, metabolic disorders, inflammation and oncology.vTv Therapeutics is advancing several proprietary drug candidates. The company's lead candidate, azeliragon (aka TTP488), is a novel, orally bioavailable small molecule compound that is being developed for the treatment of Alzheimer's disease. In Phase 2 clinical trial in patients with mild to moderate Alzheimer's disease, azeliragon showed a statistically significant difference of more than 3 points in ADAS-cog at 18 months compared to placebo.Azeliragon has been granted Fast Track Designation and agreement on its Phase 3 protocol has been reached with FDA via a Special Protocol Assessment (SPA). The Phase 3 study in patients with mild Alzheimer's disease was initiated in April 2015 with a clear path forward to registration with the aim to demonstrate disease modification.vTv Therapeutics is also prosecuting the clinical development of TTP399, a novel functionally liver-selective Glucokinase Activator ("GKA") for the treatment of type 2 diabetes. In a Phase 2a study, TTP399 normalized patients' HbA1c without inducing hypoglycemia, after only six weeks of treatment. A six-month Phase 2 study is ongoing.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Alexandria Venture Investments
VC Fund · Pasadena, California, United States · 2 investments in France Life Science startups, 15 in the past 12 months

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 297
  • Round size: Seed $2M–$30M; Series A $12M–$100M; Series B $25M–$150M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Leal Therapeutics — Leal Therapeutics develops novel therapeutics for patients.
  • Vedana Therapeutics — Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.
  • Khartis Therapeutics — Khartis is a drug discovery company developing oral therapies for patients with immune-mediated and chronic diseases. The company focuses on discovering and developing drug candidates intended to address chronic conditions and immune-mediated diseases.
Show all investments...

European Commission
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in France Life Science startups, 47 in the past 12 months

The official website of the European Commission, providing access to information about its political priorities, policies and services

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Grant, Seed, Pre-Seed
  • Geography: France, Spain, Germany

Investor stats

  • Total investments: 307
  • Round size: Seed $117k–$10M; Grant $117k–$51M; Pre-Seed $55k–$5.4M
  • Lead/follow: 68% lead, 32% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Olenbee — Olenbee develops fintech solutions that connect employee benefits directly to everyday card spending. The company offers a mobile application and employer platform that link meal vouchers, gift vouchers and other planned benefits to employees’ usual bank cards and accounts. Its title-restaurant product Olenfood allows food-related expenses to beidentified from card transactions and reimbursed in line with regulation. The Olengift service applies the same principle to gift vouchers without dedicated cards or closed merchant networks. Olenbee also works on additional benefit lines such as culture, sustainable mobility, sport, holidays and home office support. Its infrastructure is designed to handle eligibility rules and integrate with HR and payroll processes for employers, while providing dedicated spaces for merchants and employees.
  • VaxThera — VaxThera develops and produces vaccines to prevents and treats diseases.
  • Sanofi Germany — Sanofi is a life sciences company specialising in the development, manufacture, and marketing of innovative therapeutic solutions.
Show all investments...

Kinled Holding
VC Fund · New York, New York, United States · 2 investments in France Life Science startups

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 144
  • Round size: Seed $594k–$14M; Series A $1.7M–$40M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
  • Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
  • Cornea Sense — CorneaSense is a medtech startup developing a non-invasive, eye-based sensing device that measures ocular surface hydration to enable early detection and monitoring of conditions such as dry eye disease and systemic health disorders. The technology aims to provide real-time, objective eye biomarkers for improved clinical diagnosis and patient care.
Show all investments...

Horizons Ventures
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 2 investments in France Life Science startups

Investing in the deep science and technology that can propel humanity towards a radically better future.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 344
  • Round size: Seed $1M–$10M; Series A $5.8M–$42M; Series B $10M–$110M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Magisto — Magisto online video editor is a fast & powerful video maker. Turn your photos and video clips into video stories with Magisto movie editor. Start free!
  • Jobspotting — Jobspotting is a recommendations engine that suggests relevant jobs to users based on their skills and experience. The engine is powered by Skills Graph and Semantic Analysis technology. The company was founded in 2013 in Berlin, Germany by ex-Googlers Hessam Lavi, Jan Backes and Manuel Holtz. Robin Haak joined the founding team in 2014 aftermeeting them through the Axel Springer Plug and Play Accelerator Programme, of which he was a co-founder. Jobspotting successfully acquired seed funding.
  • Atomo Coffee — Atomo Coffee is a developer of molecular coffee. Atomo has reverse-engineered the coffee bean to create a smooth cup of coffee, made of naturally derived ingredients, and more sustainable than current commercial coffee.
Show all investments...

Point Nine
VC Fund · Berlin, Berlin, Germany · 2 investments in France Life Science startups

Point Nine Capital is a Berlin-based venture capital firm focused exclusively on early-stage Internet investments in areas like Software-as-a-Service (SaaS), online marketplaces, and mobile.The fund and its managers, Pawel Chudzinski and Christoph Janz have backed a number of highly successful Internet companies such as Delivery Hero, Clio,Shiftplanning, Vend, Typeform, and Zendesk from their earliest stages.

Show more...

Investment focus

  • Industry: Software, SaaS, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: Germany, United States, France

Investor stats

  • Total investments: 309
  • Round size: Seed $900k–$7.5M; Series A $3.2M–$24M; Series B $9M–$62M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — raised $173M in 2022

Portfolio highlights

  • Kaiko — Kaiko provides real-time and historical cryptocurrency trade data, order books, and aggregated prices through a cryptocurrency API, downloadable CSV files, and a livestream WebSocket. We cover 100+ crypto exchanges and 35,000+ trading pairs for Bitcoin, Ethereum, and altcoins.
  • Delivery Hero — Delivery Hero is the world's leading local delivery company. We are on a mission to deliver an amazing experience - fast, easy, and to your door.
  • Polar Analytics — Your Shopify Analytics. Effortless. Centralized. Smart. Connect your datasource in one clic, automatically calculate KPIs. Visualize them all in one place. Get alerts and recommendations in realtime
Show all investments...

Invus
VC Fund · New York, New York, United States · 2 investments in France Life Science startups

Invus recognizes that every company is unique and that extraordinary business performance cannot be achieved by following a formulaic approach. Due to their unique structure, they have a great deal of flexibility in the types of companies and situations where they can get involved.They know that real transformation takes time and that it is nevera straight line. They fully align their incentives with their partners and have the wherewithal and long-term commitment to see through any bumps along the way.They have been successfully empowering owner-managers since 1985. They have been reinvesting the same pool of money from the same group of European families (through their Artal investment vehicle) since their founding. Today they manage over $4 billion in an evergreen fund and work out of offices in New York, London, Paris and Hong Kong.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series C, Series A
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 302
  • Round size: Series A $14M–$200M; Series B $35M–$230M; Series C $31M–$165M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: May invest from a new fund soon — raised $210M in 2021

Portfolio highlights

  • Aive — Turn 1 master into unlimited, brand-controlled versions. Automate post-production, scale your output, and take back control of video performance.
  • Gossamer Bio — Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focuson areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
  • Zero Motorcycles — Manufacturer of 100% electric motorcycles for the street and dirt
Show all investments...

Air Street Capital
VC Fund · London, England, United Kingdom · 2 investments in France Life Science startups

Air Street Capital provides venture capital funding and strategic support focused on early-stage companies that develop products based on artificial intelligence. It invests primarily at pre-seed, seed, and Series A stages in firms working on AI-first technology, software infrastructure, machine-learning tools, and AI-enabled life scienceapplications. The firm pairs capital investment with advisory input on product, market, and technology strategy, and facilitates connections to its broader network of AI and technology stakeholders. Air Street Capital also shares industry insights through publications and community initiatives aimed at supporting AI and related tech ecosystems.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 49
  • Round size: Seed $1.8M–$14M; Pre-Seed $1.1M–$14M; Series A $14M–$48M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely actively investing — fresh fund, raised $232M in 2026

Portfolio highlights

  • Jack & Jill AI — Jack helps candidates find the perfect job and Jill helps companies find the perfect candidate.
  • Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
  • Macrodata Labs — Turn Physical AI data into training signal: 3D hand tracking, automated QA, and action labeling at scale for robot and egocentric datasets.
Show all investments...

AQUITI Gestion
VC Fund · Bordeaux, Aquitaine, France · 2 investments in France Life Science startups

Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: France, United States

Investor stats

  • Total investments: 60
  • Round size: Seed $531k–$6.5M; Series A $849k–$18M; Venture - Series Unknown $1.2M–$12M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — raised $7.9M in 2010

Portfolio highlights

  • Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
  • RelaiSanté — RelaiSanté provides a digital platform that connects hospitals and home care providers to coordinate patient return home.
  • CardNexus — CardNexus provides a digital platform for managing, trading, and selling trading card collections.
Show all investments...

Thia Ventures
VC Fund · Genève, Geneve, Switzerland · 2 investments in France Life Science startups

WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series A, Seed, Pre-Seed
  • Geography: United States, France, Denmark

Investor stats

  • Total investments: 22
  • Round size: Seed $3.4M–$20M; Series A $6.8M–$48M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
  • uFraction8 — Multi-award-winning, innovative, microfluidics-based filter systems to provide bio-manufacturers with energy-efficient & ultra-scalable bioprocessing systems.
  • Switch Bioworks — Switch Bioworks engineers symbiotic microbes to produce sustainable nitrogen fertilizer under the control of precise genetic circuits.
Show all investments...

Sofimac Investment Managers
VC Fund · Clermont-ferrand, Auvergne, France · 2 investments in France Life Science startups

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Venture - Series Unknown, Seed
  • Geography: France, Italy, Austria

Investor stats

  • Total investments: 74
  • Round size: Seed $268k–$3.1M; Venture - Series Unknown $556k–$8.7M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
  • Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
  • Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Heartcore Capital
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in France Life Science startups

Heartcore Capital invests in companies re-enchanting the world through technology.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Seed, Series A, Series B
  • Geography: United States, Denmark, Germany

Investor stats

  • Total investments: 217
  • Round size: Seed $1.2M–$11M; Series A $3.4M–$27M; Series B $9.5M–$58M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely actively investing — fresh fund, raised $179M in 2024

Portfolio highlights

  • Davis AI — Davis AI provides AI-driven real estate development services focused on early-stage feasibility studies and architectural design. The company combines proprietary generative models, including its Gaudi-1 architectural generation model, with in-house architects to deliver site analysis, regulatory diagnostics, volumetrics, financial modeling, andinvestment analysis. Davis AI also produces architectural outputs such as floor plans, unit mix optimization, and space planning. Its workflow ingests client data rooms and enriches them with regulatory, market, and site data, turning these into constraints that guide every result. Outputs are refined and validated by human experts before delivery and are intended for real estate developers, investors, and other project stakeholders.
  • Fora — Fora's expert travel advisors will help you plan your dream trip while unlocking exclusive perks and upgrades. Welcome to the modern travel agency.
  • PhaseTree — Materials design simulation company - PhaseTree ApS
Show all investments...

Eutopia VC
VC Fund · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Eutopia is a fund for consumer startups. We back founders who are rethinking the way we eat, shop, sleep and feel. We are backing 26 startups

Show more...

Investment focus

  • Industry: E-Commerce, Retail, Food and Beverage
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: France, Belgium, Denmark

Investor stats

  • Total investments: 16
  • Round size: Seed $2.4M–$10M; Series A $4M–$48M; Venture - Series Unknown $1.3M–$9.4M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $45M in 2019

Portfolio highlights

  • Bastille — Bastille is a brand of urban bicycles. The Astir brand is synonymous with folding bicycles. The primary quality constraint Bastille, a British designer, aims to create a folding motorcycle with standard wheels rather than the mini 16-inch wheels that are traditionally associated with folding bikes.
  • Moderato — Moderato is a retail and wholesale company that manufactures and supplies a range of beverages online to various sectors.
  • SPRiNG Collective — SPRiNG is a consumer goods company that offers clean and efficient laundry and cleaning products, delivered in a 100% plastic-free box and directly in the mailbox. The company is headquartered in Paris, Ile-de-France, France by Philippe Cantet, Laure Favre, and Ben Guerville in 2017.
Show all investments...

Siparex Groupe
VC Fund · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Siparex, France,s first multi-sectoral private equity investment company, is founded in Lyon.It was a start-up at a time when the spirit of enterprise was flagging. It emerged in one of France's regions, listed the shares of the original company one of its main vehicles on the stock market, grew internationally, and has become one of theindependent groups in its line of business in the space of 30 years.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Information Technology
  • Stage:Private Equity, Series A
  • Geography: France, United States, Italy

Investor stats

  • Total investments: 129
  • Round size: Series A $1.5M–$11M; Private Equity $1.7M–$27M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: Likely still investing — raised $452M in 2022

Portfolio highlights

  • Cofarco — Official COFARCO twitter account. Commodity finance and trade credit insurance specialist.
  • DESTIA Group — DESTIA Group is a provider of personal services to different aged people.
  • Ekoscan Integrity — Ekoscan Integrity is an innovative solution for the integrity and sustainability of industrial products through the implementation of innovative technology.
Show all investments...

Agrinvest
VC Fund · Paris, Ile-de-France, France · 1 investments in France Life Science startups

Aurinvest is a venture capital fund it is managed and primarily funded by more than fifty entrepreneurs and business leaders, alongside with institutional investors. The company's goal is to invest in high growth companies or ventures which are on the edge of an exciting journey. It accompanies the founders in successfully carrying out theirplan. With this purpose, each holding is coached by two experienced professionals who stay in close contact with companies' management and who interface with Aurinvest's network.

Show more...

Investment focus

  • Industry: Software, Biotechnology, E-Commerce
  • Stage:Series B, Series A
  • Geography: France, United States, Belgium

Investor stats

  • Total investments: 32
  • Lead/follow: no public data

Portfolio highlights

  • Famoco — Famoco provides an Enterprise Mobility Management (EMM) solution with a range of secure, remotely managed Android devices. Famoco offers...
  • PathoQuest — PathoQuest provides a pioneering next generation sequencing (NGS) approach to biologics characterization and release testing
  • Evercontact — Let Evercontact connect the dots in your life by turning your emails into an always-updated address book!
Show all investments...

ADI Nouvelle-Aquitaine
VC Fund · Pessac, Aquitaine, France · 1 investments in France Life Science startups

ADI Nouvelle-Aquitaine is a non-profit organization that renders fundraising, strategy, innovation management, and support services.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Waste Management
  • Stage:Seed
  • Geography: France

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Dionymer — dionymer creates endless opportunities for a multitude of industries. Replacing petrochemical polymers with a circular and biodegradable alternative.
  • Midipile Mobility — Midipile Mobility is a B2B subscription-based turnkey service for logistics professionals. They target middle mile and last mile deliveries.Their service is built on a new type of vehicle: 4 wheels, closed body, solar, 45 km/h (28 mph). It includes fleet management tools (SaaS), insurance, maintenance and assistance. Midipile is a low-carbonalternative to delivery trucks independent from the grid thanks to free solar energy and battery swapping solution.Their services offers the guarantee of better profitability combined with a unique user experience and a controlled and quantified carbon footprint.
Show all investments...

Inserm Transfert Initiative
VC Fund · Paris, Ile-de-France, France · 1 investments in France Life Science startups

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: France, Switzerland, United States

Investor stats

  • Total investments: 21
  • Lead/follow: no public data

Portfolio highlights

  • Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
  • VectivBio — We Are Ironwood
  • Aelis Farma — Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways.Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.
Show all investments...

Crédit Mutuel Innovation
VC Fund · Paris, Ile-de-France, France · 1 investments in France Life Science startups

Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 85
  • Lead/follow: no public data

Portfolio highlights

  • UroMems — The device is developing an active implantable medical device based on the cutting edge technologyl in the field of embedded systems and micro-technologies for the development of its products.
  • Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
  • Planity — Planity, a platform that allows you to book an appointment with a professional in the beauty sector in a few clicks and quickly find a hair salon, beauty institute, barber near you
Show all investments...

Societe Generale Asset Management
VC Fund · Paris, Ile-de-France, France · 1 investments in France Life Science startups

SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series B, Series A
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 47
  • Lead/follow: no public data

Portfolio highlights

  • Augure — Improve your brand performance with Launchmetrics' leading software solutions for fashion, lifestyle and beauty brands
  • Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
  • METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.
Show all investments...

Gimv
VC Fund · Antwerpen, Antwerpen, Belgium · 1 investments in France Life Science startups

Gimv, a trusted European investment company, helps mid-market businesses create sustainable value through growth capital and expertise across diverse sectors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Private Equity
  • Geography: Belgium, United States, France

Investor stats

  • Total investments: 155
  • Lead/follow: no public data

Portfolio highlights

  • Curana — Curana is a manufacturer of bike equipment and accessories.
  • Kivu Bioscience — At Kivu Bioscience, we leverage advanced, next-generation proprietary ADC technologies to deliver more precise and effective cancer treatments.
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Show all investments...

Florac
VC Fund · Paris, Ile-de-France, France · 1 investments in France Life Science startups

Florac is a mid-market investment firm that invests and supports management teams with defensible market-leading positions.It invests in single amounts in equity and quasi-equity with a flexible exit horizon alongside founders, managers, and strategic partners in companies with strong development potential and managed by excellent managementteams. The firm is wholly-owned by the Meyer family and investing only funds of the family.Léopold Meyer headquartered the firm in Paris, Ile-de-France in 2009.

Show more...

Investment focus

  • Industry: Sales, E-Commerce, Health Care
  • Stage:Series A, Private Equity
  • Geography: France

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • DocCity — DocCity LifeSciences creates and provides outstanding spaces to house cutting-edge healthcare businesses. DocCity provides clinicians with state-of-the-art, fully furnished health spaces with roomy, well-lit, and digitally equipped consultation rooms and reception areas.
  • Clubfunding — ClubFunding is a crowdfunding platform. They offer small to medium-sized enterprises assistance in finding alternative financing from assets, individuals, and institutions.
  • Bricoprivé.com — Bricoprive.com runs a dozen daily flash sales offering a wide range of professional-quality products to its six million members. On the back of a strong value proposition, unrivalled expertise in sourcing quality products in partnership with suppliers and solid digital experience, the company has evolved to become one of the leaders in the sector.
Show all investments...

Life Science VC funding in France at a glance

Stats across 247 deals from 322 investors.

322
investors
in France Life Science startups
247
deals
in France Life Science startups
$4.3M
median round
in France Life Science startups
37%
lead investors
lead at least one round
19%
Seed
most common funding stage

Access all 322 VC funds in France Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 322 VC funds investing in France Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists